Page 44 - Read Online

Page 14 of 14 Orekhov et al. Vessel Plus 2019;3:3 I http://dx.doi.org/10.20517/2574-1209.2018.80

aorta. I. Lipid composition of aortic tissue and enzyme isolated and cultured cells. Exp Mol Pathol 1985;42:117-37.
68. Orekhov AN, Tertov VV, Kudryashov SA, Khashimov KhA, Smirnov VN. Primary culture of human aortic intima cells as a model for
testing antiatherosclerotic drugs. Effects of cyclic AMP, prostaglandins, calcium antagonists, antioxidants, and lipid-lowering agents.
Atherosclerosis 1986;60:101-10.
69. Orekhov AN, Sobenin IA, Korneev NV, Kirichenko TV, Myasoedova VA, et al. Anti-atherosclerotic therapy based on botanicals. Recent
Pat Cardiovasc Drug Discov 2013;8:56-66.
70. Kirichenko TV, Sobenin IA, Nikolic D, Rizzo M, Orekhov AN. Anti-cytokine therapy for prevention of atherosclerosis. Phytomedicine
2016;23:1198-210.
71. Kirichenko TV, Myasoedova VA, Orekhova VA, Ravani AL, Nikitina NA, et al. Phytoestrogen-rich natural preparation for treatment of
climacteric syndrome and atherosclerosis prevention in perimenopausal women. Phytother Res 2017;31:1209-14.
72. Slevin M, Ahmed N, Wang Q, McDowell G, Badimon L. Unique vascular protective properties of natural products: supplements or
future main-line drugs with significant anti-atherosclerotic potential? Vasc Cell 2012;4:9.
73. Orekhov AN, Sobenin IA. Modified and dysfunctional lipoproteins in atherosclerosis: effectors or biomarkers? Curr Med Chem 2018;
doi: 10.2174/0929867325666180320121137.